Nifty

:

24346.70

Sensex

:

80501.99

12.50 (0.05%)
259.75 (0.32%)

Login

Nifty
Sensex

:
:

24346.70
80501.99

12.50 (0.05%)
259.75 (0.32%)

Auro Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 530233 | NSE: Not Listed

Watchlist

NSE BSE

230.35

06-Feb-2025

Open
High
Low
Previous Close

238.00
247.35
228.00
235.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4236
10.04
307.20
156.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

153.51
44.07
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

187.03
N/A
3.54

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.09
4.14
1.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.76
11.22
18.17

PAT CAGR (%)

10 Years
5 Years
3 Years

25.56
13.98
39.98

P:E (Median)

8 Years
5 Years
3 Years

13.49
15.98
21.85

P:BV (Average)

8 Years
5 Years
3 Years

2.19
2.23
2.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.06
10.06
12.84

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 3.06 17.98 -82.98% 3.10 0.00 0 5.72 10.18 -43.81% 12.06 13.53 -10.86%
Expenses 2.61 13.90 -81.22% 2.38 0.00 0 4.40 9.03 -51.27% 9.65 11.17 -13.61%
EBITDA 0.44 4.08 -89.22% 0.72 0.00 0 1.32 1.15 14.78% 2.41 2.35 2.55%
EBIDTM 14.50% 22.69% 23.32% 0.00% 23.13% 11.32% 19.97% 17.39%
Other Income 0.14 0.42 -66.67% 0.31 0.00 0 0.20 0.37 -45.95% 0.40 0.62 -35.48%
Interest 0.25 0.45 -44.44% 0.28 0.00 0 0.25 0.27 -7.41% -0.33 0.13 -
Depreciation 0.27 0.27 0.00% 0.27 0.00 0 0.27 0.27 0.00% 0.28 0.30 -6.67%
PBT 0.07 3.79 -98.15% 0.48 0.00 0 1.01 0.98 3.06% 2.85 2.53 12.65%
Tax 0.02 1.05 -98.10% 0.12 0.00 0 0.25 0.27 -7.41% 0.53 0.75 -29.33%
PAT 0.05 2.73 -98.17% 0.36 0.00 0 0.75 0.71 5.63% 2.32 1.78 30.34%
PATM 1.67% 15.21% 11.58% 0.00% 13.16% 6.95% 19.23% 13.18%
EPS 0.08 4.41 -98.19% 0.58 0.00 0 1.21 1.14 6.14% 3.74 2.88 29.86%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 23.94 53.64 52.89 50.87 54.25 43.79 46.82 40.79 35.47 27.91 32.65 Net Sales Growth -42.58% 1.42% 3.97% -6.23% 23.89% -6.47% 14.78% 15.00% 27.09% -14.52% Cost Of Goods Sold 8.49 26.56 35.69 32.78 28.55 24.48 28.62 24.72 22.42 18.14 22.83 Gross Profit 15.45 27.08 17.20 18.08 25.70 19.31 18.20 16.07 13.06 9.77 9.82 GP Margin 64.55% 50.48% 32.52% 35.54% 47.37% 44.10% 38.87% 39.40% 36.82% 35.01% 30.08% Total Expenditure 19.04 42.97 48.50 46.24 43.01 37.52 39.83 34.44 31.05 25.11 29.71 Power & Fuel Cost - 2.43 2.08 1.67 1.60 1.69 1.64 1.48 1.29 1.02 1.40 % Of Sales - 4.53% 3.93% 3.28% 2.95% 3.86% 3.50% 3.63% 3.64% 3.65% 4.29% Employee Cost - 3.91 3.76 3.69 3.63 3.47 2.87 2.79 2.71 2.37 2.17 % Of Sales - 7.29% 7.11% 7.25% 6.69% 7.92% 6.13% 6.84% 7.64% 8.49% 6.65% Manufacturing Exp. - 1.60 1.47 1.65 2.09 1.72 1.32 1.25 1.24 1.02 1.07 % Of Sales - 2.98% 2.78% 3.24% 3.85% 3.93% 2.82% 3.06% 3.50% 3.65% 3.28% General & Admin Exp. - 3.59 2.46 3.46 3.39 3.44 2.48 1.96 1.28 0.78 0.52 % Of Sales - 6.69% 4.65% 6.80% 6.25% 7.86% 5.30% 4.81% 3.61% 2.79% 1.59% Selling & Distn. Exp. - 3.28 2.23 2.51 2.45 1.48 1.75 1.29 1.16 1.25 1.50 % Of Sales - 6.11% 4.22% 4.93% 4.52% 3.38% 3.74% 3.16% 3.27% 4.48% 4.59% Miscellaneous Exp. - 1.60 0.82 0.48 1.29 1.23 1.16 0.96 0.94 0.53 1.50 % Of Sales - 2.98% 1.55% 0.94% 2.38% 2.81% 2.48% 2.35% 2.65% 1.90% 0.67% EBITDA 4.89 10.67 4.39 4.63 11.24 6.27 6.99 6.35 4.42 2.80 2.94 EBITDA Margin 20.43% 19.89% 8.30% 9.10% 20.72% 14.32% 14.93% 15.57% 12.46% 10.03% 9.00% Other Income 1.05 1.50 0.94 1.09 0.76 0.97 0.96 0.51 0.53 0.42 0.24 Interest 0.45 0.74 0.81 0.83 0.46 0.58 0.87 1.21 1.18 1.66 1.66 Depreciation 1.09 1.09 1.07 1.02 1.04 1.02 1.01 0.93 0.86 0.68 0.72 PBT 4.41 10.35 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 0.80 Tax 0.92 2.55 1.00 1.03 3.33 1.59 1.67 1.20 2.11 0.00 0.00 Tax Rate 20.86% 24.64% 28.99% 26.61% 31.68% 28.19% 27.51% 25.37% 72.26% 0.00% 0.00% PAT 3.48 7.79 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 0.80 PAT before Minority Interest 3.48 7.79 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 0.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.54% 14.52% 4.61% 5.58% 13.24% 9.25% 9.40% 8.65% 2.31% 3.15% 2.45% PAT Growth -33.33% 219.26% -14.08% -60.45% 77.28% -7.95% 24.65% 330.49% -6.82% 10.00% EPS 5.61 12.56 3.94 4.58 11.58 6.53 7.10 5.69 1.32 1.42 1.29

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 41.96 34.20 31.52 28.58 21.50 17.41 12.98 9.41 8.59 7.70 Share Capital 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 Total Reserves 35.73 27.97 25.29 22.35 15.27 11.18 6.75 3.18 2.35 1.47 Non-Current Liabilities 19.84 3.66 3.31 4.07 4.72 6.06 7.89 11.40 7.23 7.52 Secured Loans 18.38 1.76 0.85 1.27 1.81 2.62 3.43 4.95 0.00 0.00 Unsecured Loans 0.00 0.26 0.81 1.12 1.35 1.95 3.02 4.93 7.23 7.52 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 23.93 18.13 20.13 9.24 6.14 9.99 9.54 5.99 9.88 13.56 Trade Payables 6.20 11.48 4.86 5.75 4.74 5.18 5.30 4.93 3.58 3.51 Other Current Liabilities 6.46 0.73 1.37 1.17 0.79 0.83 1.48 1.06 0.90 1.16 Short Term Borrowings 7.80 4.26 11.79 0.66 0.00 3.53 2.75 0.00 5.39 8.89 Short Term Provisions 3.47 1.66 2.11 1.65 0.61 0.45 0.00 0.00 0.00 0.00 Total Liabilities 85.73 55.99 54.96 41.89 32.36 33.46 30.41 26.80 25.70 28.78 Net Block 22.15 12.62 13.61 13.56 14.24 14.59 13.02 13.00 9.13 9.80 Gross Block 36.10 25.47 25.39 24.32 23.96 23.29 20.72 19.76 15.50 15.49 Accumulated Depreciation 13.95 12.85 11.78 10.76 9.73 8.70 7.69 6.76 6.37 5.68 Non Current Assets 54.88 20.33 17.61 13.94 14.40 14.75 14.74 13.28 13.25 11.28 Capital Work in Progress 32.68 7.67 3.67 0.13 0.12 0.12 1.07 0.23 3.33 0.82 Non Current Investment 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 0.00 0.00 0.28 0.20 0.00 0.00 0.59 0.00 0.74 0.61 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 30.85 35.66 37.35 27.96 17.95 18.71 15.67 13.53 12.45 17.50 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 8.24 11.76 4.25 2.55 4.06 3.37 1.49 1.33 4.31 5.59 Sundry Debtors 13.39 12.40 13.61 7.30 5.78 8.50 8.37 7.69 5.05 8.48 Cash & Bank 1.65 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 Other Current Assets 7.57 1.07 4.87 3.50 2.42 2.73 3.56 3.51 2.55 2.99 Short Term Loans & Adv. 6.70 8.01 2.22 0.08 0.48 0.28 0.27 1.10 0.26 0.92 Net Current Assets 6.92 17.53 17.22 18.72 11.81 8.72 6.13 7.54 2.57 3.94 Total Assets 85.73 55.99 54.96 41.90 32.35 33.46 30.41 26.81 25.70 28.78

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 18.81 3.28 -6.59 12.82 9.30 6.87 4.77 5.85 7.88 -0.78 PBT 10.35 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 0.80 Adjustment 2.08 2.13 1.60 1.33 1.64 1.72 2.02 1.88 2.16 2.22 Changes in Working Capital 6.38 -2.30 -12.07 0.98 2.02 -0.92 -0.69 1.68 4.84 -3.81 Cash after chg. in Working capital 18.81 3.28 -6.59 12.82 9.30 6.87 6.05 6.49 7.88 -0.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 -1.28 -0.64 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -38.67 -5.08 -5.34 -3.51 -2.21 -3.19 -1.75 -1.56 -2.44 -0.73 Net Fixed Assets -35.64 -4.08 -4.61 -0.37 -0.67 -1.62 -1.80 -1.16 -2.52 -0.78 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -3.03 -1.00 -0.73 -3.14 -1.54 -1.57 0.05 -0.40 0.08 0.05 Cash from Financing Activity 19.09 -8.18 9.79 -0.46 -5.52 -1.83 -1.77 -3.81 -5.34 0.53 Net Cash Inflow / Outflow -0.77 -9.98 -2.14 8.85 1.58 1.86 1.24 0.47 0.09 -0.98 Opening Cash & Equivalents 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 1.42 Closing Cash & Equivalent 1.65 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 67.32 54.87 50.58 45.86 34.49 27.94 20.82 15.10 13.78 12.36 ROA 11.00% 4.40% 5.87% 19.34% 12.32% 13.78% 12.34% 3.11% 3.24% 2.89% ROE 20.46% 7.43% 9.47% 28.67% 20.84% 28.95% 31.53% 9.06% 10.83% 11.01% ROCE 20.37% 9.92% 12.20% 38.88% 24.80% 29.12% 28.65% 20.24% 11.21% 10.76% Fixed Asset Turnover 1.74 2.08 2.05 2.25 1.85 2.13 2.02 2.10 1.90 2.21 Receivable days 87.78 89.77 75.03 44.00 59.53 65.79 71.86 62.81 83.84 68.35 Inventory Days 68.04 55.24 24.40 22.23 30.99 18.96 12.60 27.79 61.30 71.45 Payable days 121.53 83.56 59.08 67.05 51.48 47.58 55.90 51.82 53.73 47.08 Cash Conversion Cycle 34.28 61.45 40.35 -0.82 39.04 37.17 28.56 38.78 91.41 92.71 Total Debt/Equity 0.63 0.19 0.44 0.11 0.15 0.46 0.71 1.05 1.47 2.13 Interest Cover 15.06 5.23 5.69 23.92 10.76 7.95 4.90 3.49 1.53 1.48

Top Investors:

kirtilaben jayantilal mehta

ushma gautam doshi

ravi parimal shah

Annual Reports:

News Update:

Auro Laboratories - Quarterly Results
14th Feb 2025, 17:45 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback